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A bstrac t—Chronic fatigue syndrome (CFS) is characterized by severe fatigue, lasting for at least 6 months, 
f o r  which no somatic explanation can be found. Because hyperventilation can produce substantial fa­
tigue, it seems worthwhile to investigate the relationship between it and CFS. It might be hypothesized 
t h a t  hyperventilation plays a causal or perpetuating role in CFS. CFS patients, non-CFS patients known 
t o  experience hyperventilation, and healthy controls were compared on complaints of fatigue and hyper­
ventilation. CFS patients and non-CFS patients known to experience hyperventilation offered substan­
t ia l  complaints of fatigue and hyperventilation, both to a similar degree. Physiological evidence of hyper­
ventilation was found significantly more often in CFS patients than in healthy controls. However, no 
significant differences between CFS patients with and CFS patients without hyperventilation were found 
o n  severity of fatigue, impairment, number of complaints, activity level, psychopathology, and depres­
sion . It is concluded that hyperventilation in CFS should probably be regarded as an epiphenome- 
non . © 1997 Elsevier Science Inc.
K eyw o rd s:  Chronic fatigue syndrome; Fatigue; Hyperventilation.
INTRODUCTION
Chronic fatigue syndrome (CFS) is defined as severe fatigue, lasting for at least 6 
months, for which no somatic explanation can be offered. The pathogenesis of CFS 
is still unknown [1], Because hyperventilation can produce substantial fatigue, and 
because fatigue is one of the main complaints in hyperventilation, it seems worth­
while to investigate their relationship. Grossman and de Swart [2] showed that 64% 
o f the patients with hyperventilation syndrome complained of tiredness. In addi­
tion, the fatigue in hyperventilation [3] as well as in CFS [4-6] seems to be of a cen­
tral type.
One might hypothesize that CFS is caused by hyperventilation. It is possible that 
stress causes hyperventilation, which in turn might lead to chronic fatigue. Another 
possibility is that hyperventilation plays a perpetuating role in CFS. Patients with
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CFS might develop hyperventilation due to their fatigue, and hyperventilation 
might in turn lead to an aggravation of fatigue.
Only a few studies have dealt with the relationship between CFS and hyperventi­
lation. Rosen et al. [7] demonstrated hyperventilation in 38 of 40 patients suffering 
from CFS and claimed that hyperventilation plays an important role in the patho­
genesis. Riley et al. [4], however, found no differences in the mean end-tidal Pco2 
both before and after exercise between 13 patients with CFS and 13 healthy con­
trols. Saisch et a l [8] found evidence for hyperventilation in 9% of 31 CFS patients 
(29%), They did not find a relationship between the severity of hyperventilation 
and the degree of functional impairment, which was to be expected when hyperven­
tilation would play a perpetuating role in CFS.
The first purpose of the present study is to determine whether there is any evi­
dence for subjective complaints of hyperventilation in CFS, and whether there is ev­
idence of fatigue in patients with hyperventilation. CFS patients and patients with 
known hyperventilation are compared to healthy controls to see whether these 
complaints are not only common but also specific for CFS and hyperventilation. 
The aim of the second part of the study is to determine whether there is any physio­
logical evidence for hyperventilation in CFS and whether CFS patients show physi­
ological evidence for hyperventilation more frequently than healthy controls. In the 
third part of the study, CFS patients with physiological evidence for hyperventila­
tion (CFS HV) are compared to CFS patients without hyperventilation (CFS non- 
HV) on severity of fatigue, impairment, number of complaints, activity level, psy­
chopathology, and depression, to determine the role of hyperventilation in CFS.
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METHOD
Subjects
For the first part of this study, 39 patients with CFS and 32 healthy controls (all from a sample de­
scribed elsewhere) [9], completed the questionnaires. The healthy controls were matched and recruited 
by a regional newspaper advertisement. Furthermore, 17 non-CFS patients with established hyperventi­
lation (non-CFS HV) participated, all from the out-patient clinic of the Department of Pulmonology, 
Dekkerswald, University of Nijmegen. For the second and third parts of the study 27 CFS patients and 
the 32 healthy controls from the first part of the study participated. The experimental groups are not o f 
an equal size because this study was linked to an already ongoing study.
All CFS patients were diagnosed at the General Internal Medicine out-patient clinic of the University 
Hospital, Nijmegen. CFS is defined as severe fatigue, lasting for at least 6 months, for which no somatic 
explanation can be offered, Patients were diagnosed with CFS if they fulfilled the Sharpe criteria [10]. 
According to these criteria, patients with a current diagnosis of major depression with melancholic o r  
psychotic features, bipolar affective disorder, schizophrenia of any subtype, delusional disorders of any 
subtype, manic depressive illness, substance abuse, eating disorder, or proven organic brain disease (de­
mentias of any subtype) were excluded.
Patients and healthy controls were diagnosed as having hyperventilation when they fulfilled three o f 
the following criteria [11]:
• Low Paco2 in rest (<4.5 kPa).
• High breathing frequency, irregular breathing, or frequent sighing in rest.
• Decreasing Paco2 in control condition on a spirometer.
• Inverted ventilatory response to co2.
• Adding co2 results in a regulation of breathing.
• One of the following criteria during or after the provocation test:
no step change in Petco2 when stopping voluntary hyperventilation;
no step change in respiratory frequency when stopping voluntary hyperventilation;
Paco2 3 minutes after the end of the provocation <90%  of the starting level.
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Instruments
Subjective fatigue  was measured with the subscale of subjective fatigue of the Checklist of Individual 
Strength (CIS) [12]. On this scale, the minimum score is 1 and the maximum score is 7.
Level o f  im pairm ent was assessed with the Sickness Impact Profile (SIP) [13]. This questionnaire mea­
sures the influence of complaints in different areas of daily functioning. For this study, eight subscales 
were used (alertness behavior, sleep, homemaking, leisure activities, work, mobility, social interac­
tions, ambulation).
Level o f  physica l activity was assessed using an actometer. This apparatus is worn around the ankle 
for 2 weeks, recording the amount of movements every 5 minutes. This information is stored to an inter­
nal memory, and can be read by use of a personal computer [14].
Subjective complaints o f  hyperventilation  were assessed by the Nijmegen Hyperventilation Question­
naire (NHQ) [15]. The cutoff score for hyperventilation is 23.
Psychopathology  was measured with the Symptom Checklist (SCL-90R), an indicator of psychological 
disturbances, and the Beck Depression Inventory (BDI) [16, 17], a standardized self-report question­
naire for measuring depression.
Respiratory measurements were performed using a hyperventilation test in which the patient was con­
nected to a closed spirometer circuit by a mouthpiece. A sampling capnograph measured Pco2 in the re­
spiratory air. Resting respiratory parameters were measured during 5 minutes: minute ventilation, 
Petco2, breathing frequency, irregularity of breathing, and the time course of Petco2 during the first 5 
minutes of the test. Next, some co2 was given in the inspiratory air, to raise Petco2 by 1.0±0,2 kPa. The 
response of the ventilation to the increase in Petco2 was measured during another 5 minutes, Subse­
quently, the patient was disconnected from the spirometer, and only Petco2 was monitored during a 
1-minute period of voluntary hyperventilation, and during the 3 minutes thereafter. The patients were 
asked whether they recognized their daily symptoms, during the hyperventilation. Finally, an arterialized 
capillary blood gas sample was taken to assess a possible metabolic acidosis, compensating for 
chronic hyperventilation.
Statistical analyses
The analysis of differences between groups on dichotomous variables was carried out with the chi- 
square test. Bonferroni correction was applied for the comparison of three experimental groups. Assum­
ing a significance level of 0.05, a difference was considered significant if the p <0.017. The analysis of dif­
ferences between two groups on ratio variables was carried out with the ¿-test, with the significance level 
set at p ~ 0.05. The analysis of differences between more than two groups on ratio variables was per­
formed by analysis of variance. Multiple comparisons were made by Duncan’s multiple range tests, 
with ¿><0,05,
RESULTS
First part
The mean age of the CFS patients was 36.5 ( s d = 8 . 8 ) ,  of the non-CFS patients 
with known hyperventilation (non-CFS HV) 44.0 (sd='12.6), and of the healthy 
controls 37.0 (sd =12.8). Only the non-CFS HV patients differed significantly in age 
from the other two groups. There were no significant differences in gender; 80% of 
the CFS patients were female, as were 59% of the non-CFS HV patients and 84% 
of the healthy controls.
Data concerning subjective complaints of hyperventilation and subjective com­
plaints of fatigue are presented in Table I. On the NHQ, 59% of the CFS patients 
scored above the cutoff score for hyperventilation. This is significantly different 
from healthy controls (3%), but not from non-CFS FIV patients (65%). Non-CFS 
HV patients had a mean CIS score for subjective fatigue of 5.2. This is significantly 
different from healthy controls (2.0), but not from CFS patients (5.9).
Second part
The CFS patients and the healthy controls who underwent respiratory measure­
ments did not differ significantly on age and gender. Mean age of the CFS patients
Table I.—Mean scores ( s d )  on subjective complaints of hyperventilation 
(NHQ), percent above the cutoff score for hyperventilation (NHQ > 
23), and mean score ( s d )  of subjective fatigue (CIS) of 39 CFS patients 
compared to 17 non-CFS patients with known hyperventilation (non-CFS
HV) and 32 healthy controls
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CFS Non-CFS HV Healthy
NHQa 25.1 31.4 (11.6) 10.4 (6.3)
NHQ% > 23b 59% 65% 3%
CIS subjective fatiguec 5.9 (1.1) 5.2 (2.2) 2.0 (1.1)
a One-way ANOVA with Duncan multiple-range test (p  < 0.05), CFS sig­
nificantly different from non-CFS HV, and healthy controls, and non-CFS IiV 
significantly different from healthy controls.
bp <  0.001; CFS significantly different from healthy controls (p < 0.001), 
and non-CFS HV significantly different from healthy controls (p < 0.001); non- 
CFS HV is not significantly different from CFS.
c One-way ANOVA, with Duncan multiple range test (p < 0.05), CFS 
significantly different from healthy controls, non-CFS HV significantly different 
from healthy controls; non-CFS HV is not significantly different from CFS.
was 36.6 (s d = 8.0), and of the healthy controls 37.0 (s d = 12.8). Seventy-eight per­
cent of the CFS patients were female, compared to 85% of the healthy controls. Be­
tween CFS patients and healthy controls significant differences were found on fa­
tigue, impairment, number of complaints, level of activity, subjective complaints of 
hyperventilation, and psychopathology, as expected [9] (Table II).
Table III shows the results of the respiratory measurements in CFS and healthy 
controls. Significantly more CFS patients showed hyperventilation (59%) than did 
healthy controls (22%). CFS patients differed from healthy controls on Petco2 and 
recognition of complaints, but not on the other respiratory parameters.
Third part
The 16 CFS patients with hyperventilation (CFS HV) and the 11 CFS patients 
without hyperventilation (CFS non-HV) were compared on subjective fatigue 
(CIS), impairment (SIP), number of complaints, activity level (actometer), subjec­
tive complaints specific for hyperventilation (NHQ score), psychopathology (SCL- 
90) and depression (BDI). No significant differences between groups were found
Table II.—Mean scores ( s d )  of 27 CFS patients and 32 healthy controls 
recruited for respiratory measurements, on subjective fatigue (CIS), 
impairment (SIP), number of complaints, activity level (actometer), 
subjective complaints of hyperventilation (NHQ), psychopathology
(SCL-90), and depression (BDI)
CFS Healthy p-value*1
CIS subjective fatigue 5.9 (1.0) 2.0 (1.1) < 0.001
SIP 17.1 (6.3) 1.2 (0.3) < 0,001
Number of complaints 7.4 (3.7) 0 (0.0) < 0.001
Actometer 25.1 (12.3) 36.4 (12.2) < 0.001
NHQ 25.6 (11.3) 10.4 (25.6) < 0.001
SCL-90 155.4 (27.2) 106.9 (22.0) < 0.001
BDI 10.6 (5.3) 2.7 (4.0) < 0.001
a Using the ¿-test.
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Table III. Mean scores (s d ) or percentage on respiratory measurements
in 27 CFS patients and 32 healthy controls
CFS Healthy p-Value
Petco2 (kPa)a 4.5 (0.66) 4.9 (0.40) <  0.005
Petco2 <  4.5” 52% 22% < 0.05
Paco2" 4.75 (0.69) 4.83 (0.57) n s
Breathing frequency3 13.1 (3.7) 15.1 (3.7) ns
Tidal volume 0.604 (0.20) 0.560 (0.18) n s
Decreasing Petco2 36% 22% n s
Irregular breathingb 30% 16% n s  
Delayed recovery after
Provocation1 56% 38% n s  
Recognition1
None 41% 81% < 0.01
Partly 37% 13% < 0.01
Completely 22% 6% < 0.01
Hyperventilation, according 59% 22% < 0.005 
to physiological criteriab
a
b
Using the ¿-test.
Using the chi-square test.
(Table IV). CFS HV patients as well as CFS non-HV patients were both extremely 
fatigued and impaired. There was neither a significant difference in the number of 
complaints, nor the level of activity or subjective complaints of hyperventilation. Fi­
nally, CFS-HV patients and CFS non-HV patients did not differ on psychopathol­
ogy and depression.
DISCUSSION
«
Patients with CFS endorsed subjective complaints of hyperventilation, similar to 
non-CFS patients with known hyperventilation. The latter showed substantial fa­
tigue, of similar severity as CFS patients. Physiological evidence for hyperventila­
tion was found significantly more often in CFS patients (59%) than in healthy con­
trols (22%), with a significant1 difference in the mean resting Petco2. Rosen et al. [7] 
found hyperventilation in 93% of the CFS patients and 55% of the healthy controls,
Table IV.—Mean scores (s d ) of 16 CFS patients with hyperventilation (CFS 
HV) and 11 CFS patients without hyperventilation (CFS non-HV) on 
subjective fatigue (CIS), impairment (SIP), number of complaints, activity 
level (actometer), subjective complaints of hyperventilation (NHQ),
psychopathology (SCL-90), and depression (BDI)
CFS HV CFS non-HV p-Valuea
CIS subjective fatigue 5.8 (1.0) 6.0 (0,9) NS
SIP score 18.2 (6.1) 16.4 (6.5) NS
Number of complaints 8.1 (3.6) 6.5 (3.7) NS
Actometer 24.1 (10.2) 26.6 (15,2) NS
NHQ 25.6 (8.2) 25.5 (15.4) NS
SCL-90 153.9 (28.1) 157.9 (27.1) NS
BDI 10.1 (4.0) 11.4 (6.9) NS
n Using the r-test
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whereas Saisch et al. [8] found evidence for hyperventilation in 29% of the CFS pa­
tients, and Riley et al. [4] found no differences in the mean Petco2 between CFS pa­
tients and healthy controls. These conflicting findings can be explained by the differ­
ences in the criteria used in diagnosing hyperventilation. In the study by Rosen et 
al. [7], less stringent criteria were used. Patients were also diagnosed with hyperven­
tilation if they had a positive “think test”: 3 minutes after the hyperventilation prov­
ocation test, patients were requested to close their eyes and think about the circum­
stances of an attack and the feelings and sensations experienced* A  fall of end-tidal 
Paco2 of 1.3 kPa or more was taken as a positive response [18]. However, the resting 
Petco2 in that study did not differ between CFS patients and healthy controls, as in 
the study of Riley et al. [4]. In the study by Saisch et al. [8], the criteria were more 
strict than in our study. Patients were diagnosed with hyperventilation only if the 
Petco2 was less than 4.0 kPa at rest, during or after exercise, or at 5 minutes after 
the end of voluntary overbreathing. Using the criterion of a Petco2 of less than 4.0 
kPa, in our study, 19% of the CFS patients and none of the healthy controls were 
diagnosed with hyperventilation. This is closer to the finding of 29% hyperventilat­
ing CFS patients found in the study by Saisch et al. [8],
If hyperventilation plays an important role in the pathogenesis or perpetuation of 
CFS, one would assume that hyperventilation is common in CFS, and one would ex­
pect higher scores of fatigue and impairment in the CFS patients with hyperventila­
tion, compared to the CFS patients without hyperventilation. Like Saisch et al. [8], 
we found physiological evidence for hyperventilation in some of the CFS patients, 
the exact percentage depending on the criteria used. In addition, we could show that 
the high percentage of 93% found in the study by Rosen et al. [7] could be explained 
by the less strict criteria used: hyperventilation in CFS is not as common as they sug­
gest. Comparing CFS patients with hyperventilation to CFS patients without hyper­
ventilation, no differences on fatigue and impairment were found, as in the study 
by Saisch et al. [8]. There were also no differences found on variables such as the 
number of complaints, level of activity, psychopathology, and depression. If hyper­
ventilation plays a role in CFS, one would at least expect some differences, Using 
the strict criteria of a 4.0 kPa Paco2 at rest, five of our CFS patients showed hyper­
ventilation. However, even then, no differences are found between CFS patients 
with and CFS patients without hyperventilation. Therefore, it is unlikely that hyper­
ventilation plays a role in the pathogenesis or perpetuation of CFS.
Depending on the criteria one uses, it can be said that signs of hyperventilation were 
found in a substantial number of the CFS patients. Furthermore, non-CFS HV pa­
tients had significantly more complaints of fatigue than healthy controls. However, we 
did not find more complaints of fatigue in hyperventilating CFS patients than in non­
hyperventilating CFS patients. Therefore, hyperventilation is probably an epiphe- 
nomenon in CFS, and does not play a substantial causal or perpetuating role.
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